agilon health
AGL
agilon health (AGL) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Underweight | $85.00 from $31.00 | Aug 24, 2026 |
| Citigroup | Upgraded | Sell → Neutral | $115.00 from $105.00 | Aug 11, 2026 |
| Wells Fargo | Maintained | Overweight | $146.00 from $141.00 | Aug 11, 2026 |
| Barclays | Maintained | Equal-Weight | $111.00 from $81.00 | Aug 6, 2026 |
| Evercore ISI Group | Maintained | In-Line | $125.00 from $120.00 | Aug 6, 2026 |
| Benchmark | Maintained | Buy | $140.00 from $95.00 | Aug 6, 2026 |
| Truist Securities | Maintained | Hold | $112.00 from $67.00 | Aug 6, 2026 |
| Citigroup | Downgraded | Neutral → Sell | $105.00 from $80.00 | Jul 23, 2026 |
| Wells Fargo | Maintained | Overweight | $141.00 from $72.00 | Jul 13, 2026 |
| Barclays | Upgraded | Underweight → Equal-Weight | $81.00 | May 26, 2026 |
| Benchmark | Maintained | Buy | $95.00 from $13.00 | May 21, 2026 |
| Citigroup | Maintained | Neutral | $80.00 from $18.75 | May 15, 2026 |
| TD Cowen | Maintained | Hold | $55.00 from $17.00 | May 11, 2026 |
| Wells Fargo | Maintained | Overweight | $72.00 from $37.50 | May 8, 2026 |
| Deutsche Bank | Upgraded | Hold → Buy | $49.00 from $33.00 | May 7, 2026 |
| Baird | Maintained | Neutral | $35.00 from $20.00 | May 7, 2026 |
| Jefferies | Upgraded | Hold → Buy | $48.00 from $27.50 | May 7, 2026 |
| Evercore ISI Group | Maintained | In-Line | $32.00 from $16.00 | May 7, 2026 |
| JP Morgan | Downgraded | Neutral → Underweight | $21.00 | May 4, 2026 |
| Benchmark | Maintained | Buy | $13.00 from $1.50 | Apr 2, 2026 |
Frequently asked questions
What is the latest analyst rating on AGL?
On Aug 24, 2026, JP Morgan maintained agilon health at Underweight with a price target of $85.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.